Banner - NPPA Connect

|Poll|August 29, 2022

POLL: Which September FDA Approval Are You Looking Forward To?

Author(s)Dermatology Times Staff

Click here to answer this week's poll.

Which September FDA Approval Are You Looking Forward To?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

POLL: When Do You Typically Initiate Biologic Therapy in Patients with CSU?

ByMarie Bosslett, Assistant Editor

April 14th 2026

Poll: Are You Attending the 50th Annual Society for Pediatric Dermatology Conference?

ByMaddi Hebebrand, MC, Associate Editor

July 23rd 2025

POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation

ByMarie Bosslett, Assistant Editor

February 28th 2025

POLL: Are You Attending the South Beach Symposium?

ByMaddi Hebebrand, MC, Associate Editor,Glynis Ablon, MD,Matthew Zirwas, MD

February 4th 2025

POLL: What Topics and Content Would You Like to See More of From Us?

ByEmma Andrus, Editor

January 20th 2025

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

FDA Grants Priority Review to Zasocitinib for Moderate-to-Severe Plaque Psoriasis

FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis

Genetic Study Links Higher BMI to Perceived Facial Aging, but Causality Remains Unproven

Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials

FDA Approves Ameluz Red Light PDT for Superficial Basal Cell Carcinoma